Pierluigi Gasparini Selected Research

Pierluigi Gasparini Research Topics

Disease

30	Neoplasms (Cancer) 10/2022 - 01/2009
10	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2010
7	Carcinogenesis 10/2021 - 05/2010
5	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2013
5	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 04/2010
4	Triple Negative Breast Neoplasms 03/2014 - 01/2013
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2023 - 01/2013
3	Lymphoma (Lymphomas) 01/2013 - 12/2010
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2019 - 04/2014
2	Malignant Mesothelioma 10/2018 - 01/2017
2	Lung Neoplasms (Lung Cancer) 12/2015 - 05/2014
2	Leukemia 01/2013 - 05/2010
1	Adenoma (Adenomas) 02/2019
1	Carcinoma (Carcinomatosis) 02/2019
1	Turcot syndrome 02/2019
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 12/2018
1	Hematologic Neoplasms (Hematological Malignancy) 12/2018
1	Lewis Lung Carcinoma 12/2018
1	Cachexia 12/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018
1	Mesothelioma 10/2018
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 02/2018
1	Neoplastic Processes 02/2018
1	Cholangiocarcinoma 01/2018
1	Adenocarcinoma 03/2017
1	Liposarcoma 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 12/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2015
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2013
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2013
1	Starvation 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 01/2011
1	B-Cell Leukemia (Leukemia, B Cell) 12/2010

Drug/Important Bio-Agent (IBA)

23	MicroRNAs (MicroRNA)IBA 10/2022 - 12/2009
7	Biomarkers (Surrogate Marker)IBA 10/2021 - 03/2014
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 04/2010
4	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 05/2010
2	Caspase 3 (Caspase-3)IBA 02/2019 - 12/2018
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018 - 01/2009
2	ErbB Receptors (EGF Receptor)IBA 12/2015 - 05/2014
2	Messenger RNA (mRNA)IBA 01/2014 - 01/2013
1	ChromatinIBA 06/2023
1	Adenosine (Adenocard)FDA LinkGeneric 10/2022
1	Protein Isoforms (Isoforms)IBA 10/2022
1	Inosine FDA Link 10/2022
1	NMS P937IBA 01/2022
1	Polo-Like Kinase 1IBA 01/2022
1	Junctional Adhesion Molecule AIBA 10/2021
1	Death-Associated Protein KinasesIBA 11/2019
1	A-Form DNA (A-DNA)IBA 02/2019
1	CaspasesIBA 02/2019
1	Caspase 7IBA 02/2019
1	Toll-Like Receptor 7IBA 12/2018
1	Long Noncoding RNAIBA 12/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2018
1	villinIBA 02/2018
1	CytokinesIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2015
1	Anaplastic Lymphoma KinaseIBA 12/2015
1	RNA (Ribonucleic Acid)IBA 05/2015
1	betaglycan (TGFBR3)IBA 05/2015
1	Differentiation AntigensIBA 12/2014
1	Calcibiotic Root Canal SealerIBA 04/2014
1	Taxoids (Taxanes)IBA 02/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2014
1	Androgen Receptors (Androgen Receptor)IBA 01/2014
1	MethyltransferasesIBA 06/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2013
1	retinoic acid receptor betaIBA 06/2013
1	Toll-Like Receptor 3IBA 06/2013
1	Poly I-CIBA 06/2013
1	GuanosineIBA 05/2013
1	Nuclear Proteins (Protein, Nuclear)IBA 05/2013
1	NucleolinIBA 05/2013
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2013
1	Estrogen ReceptorsIBA 01/2013
1	Proteasome InhibitorsIBA 01/2013
1	Bortezomib (Velcade)FDA Link 01/2013
1	Estrogens (Estrogen)FDA Link 01/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2013
1	Hormones (Hormone)IBA 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 01/2013
1	Untranslated RNA (Noncoding RNA)IBA 01/2011
1	ElementsIBA 01/2011
1	TensinsIBA 12/2010
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2010
1	Indicators and Reagents (Reagents)IBA 12/2010
1	Estrogen Receptor alphaIBA 05/2010

Therapy/Procedure

10	Therapeutics 02/2019 - 05/2010
3	Drug Therapy (Chemotherapy) 01/2018 - 02/2010
1	Transplantation 12/2018
1	Chemoprevention 02/2018
1	Secondary Prevention 03/2017
1	Adjuvant Radiotherapy 03/2014
1	Precision Medicine 10/2013
1	Heterologous Transplantation (Xenotransplantation) 01/2013